Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • Drug Charts
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (648)
    • Blood Glucose Meters (3)
    • Complications (177)
    • Diabetes in Pregnancy (14)
    • Diabetes Meds (68)
    • Drug-Induced Hypo/Hyperglycemia (133)
    • Monitoring (121)
    • Natural Medicines/Supplements (13)
    • Prevention (56)
    • Treatment (323)
  • Endocrinology (12)
  • Hyperglycemia (27)
  • Hypoglycemia (28)
  • Other (26)
  • Prediabetes (5)
  • Resources (221)
  • Thyroid Disorders (49)
211 - 225 of 648 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: association between the SGLT2 inhibitor, Invokana (canagliflozin), and bone fractures December 2015
PL Voices: Helping Patients Stick with Metformin December 2015
Commentary: Canagliflozin (Invokana, Invokamet) Bone Fracture Risk December 2015
PL Voices: Cardiovascular Outcomes with Empagliflozin (Jardiance) November 2015
PL Voices: Insulin Analogs versus Human Insulin November 2015
Article: more clarity on treating neuropathic pain November 2015
Article: Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon November 2015
Article: how regular or NPH insulin compares to insulin analogs in type 2 diabetes November 2015
Commentary: Empagliflozin and Cardiovascular Disease November 2015
Chart: How to Switch Insulin Products November 2015
Article: Listen for Gliptin Patients Complaining of Severe Joint Pain October 2015
Article: Stop Repaglinide and Switch to Another Diabetes Med in Clopidogrel Patients October 2015
Other: Canada Vigilance October 2015
Commentary: Drug Interaction: Clopidogrel (Plavix) and Repaglinide (GlucoNorm) October 2015
Commentary: Corticosteroids for Community-Acquired Pneumonia October 2015
  • « Prev
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved